title: Reframing risk part I: Legal and ethical standards for medical risk disclosure.
authors.affiliation: Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia; Emory Center for Ethics, Atlanta, Georgia. Electronic address: bstoff@emory.edu.
authors.forename: Benjamin K
authors.initials: BK
authors.lastname: Stoff
authors.forename: Deborah
authors.initials: D
authors.lastname: Cruze
authors.forename: Robert A
authors.initials: RA
authors.lastname: Swerlick
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use; D003880:Dermatology / Q000941:ethics / Q000592:standards; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016365:Liability, Legal; D061214:Patient Safety; D010390:Pemphigoid, Benign Mucous Membrane / Q000175:diagnosis / Q000188:drug therapy*; D010817:Physician-Patient Relations / Q000941:ethics; D018570:Risk Assessment; D000069283:Rituximab; D014342:Truth Disclosure / Q000941:ethics*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab